And the team is still not complete.... I can't wait to see who's next to climb aboard...
The Company will soon announce the appointment of the Company's Chief Science Officer (CSO) and Chief Medical Officer (CMO), as well as other essential corporate officers and directors, whose focus will be to ensure the advancement of scientific investigations that support the commercial advancement of regulatory reviews for domestic and international market approvals for Kaposi's Sarcoma as well as for squamous and basal cell carcinomas.